+1-888-308-5802     
News Contact Us

Pet Cancer Therapeutics Market 2020 Regional Growth Drivers, Opportunities, Trends, and Forecasts to 2025

Author : Ronak Bora | Published Date : 2020-09-17 

Pet Cancer Therapeutics Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.

A rise pet population with a growing expenditure on pet healthcare will spur the pet cancer therapeutics market forecast. The growth can be credited to an increasing need for companionship in the developed countries. The American Society for the Prevention of Cruelty to Animals (ASPCA), reveals that the American pet owners averagely spend about USD 235 annually on dogs and USD 160 on cats’ health.

The pet cancer therapeutics providers are involved in acquisitions and collaborations to expand their market value and geographic reach. Some of the prominent companies are, Merial, Zoetis, AB Science, VetDC, Aratana Therapeutics, Vetivax, Karyopharms Verdinexor, and Regeneus.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/2017

Reportedly, the global pet cancer therapeutics market size will surpass USD 359.4 million by 2025 in terms of annual revenues. Remunerations for the industry from chemotherapy segment will hit USD 211 million by 2025 owing to the number of products for tumor growth control in the form of intravenous and oral administrations, urging the demand for pet cancer therapies.

With respect to geographical terrain, the UK pet cancer therapeutics industry has emerged as a profitable revenue ground owing to the availability of pet cancer vaccines in most of the regions before chemotherapy drugs. The researchers and pet care companies are constantly working towards developing new vaccines and medications which will support the regional business growth.

Lymphoma type of cancer led the pet cancer drugs industry over the last couple of years due to the wide availability of the products towards the treatment of this type of cancer that pets like cats and dogs suffer from. Lymphoma is regarded as the most common type of cancer found in both dogs and cats. As per reliable sources, lymphoma is responsible for nearly 7-14% of all cancers diagnosed in dogs. 

Concerning species, dogs have dominated the industry outlook owing to the growing demand for adoption of dogs and the willingness of the owners to offer quality pet care and veterinary treatment such as food and supplements.

Pet cancer therapeutics companies are constantly working towards enhancing the product offerings to meet the requirements of the consumers and to achieve a competitive edge. For instance, Colorado-based VetDC – a veterinary cancer therapeutics firm in the year 2017, launched TANOVEA™- CA1 which received approval from the U.S. FDA’s center for veterinary medicine, making the novel medicine a new animal drug used towards the treatment of lymphoma in dogs.

Browse full table of contents (TOC) of this report @ https://www.gminsights.com/toc/detail/pet-cancer-therapeutics-market

Partial Chapter of the Table of Content 

Chapter 4. Pet Cancer Therapeutics Market, By Medicine Type

4.1. Key segment trends

4.2. Chemotherapy drugs

4.2.1. Market size, by region, 2014 – 2025 (USD Million)

4.3. Vaccines

4.3.1. Market size, by region, 2014 – 2025 (USD Million)

Chapter 5. Pet Cancer Therapeutics Market, By Species

5.1. Key segment trends

5.2. Dogs

5.2.1. Market size, by region, 2014 – 2025 (USD Million)

5.3. Cats

5.3.1. Market size, by region, 2014 – 2025 (USD Million)

 

About Author

Ronak Bora

Ronak Bora

A graduate in Electronics Engineering, Ronak writes for fractovia and carries a rich experience in digital marketing, exploring how the online world works from a technical and marketing perspective. His other areas of interest include reading, music, and sport. [email protected] | https://twitter.com/RonakBora26

Related News

North America Dental Implants Market Size to Surpass USD 1.78 Billion by 2024

Published Date: 2020-09-25         Author: Ronak Bora

The research report on North America Dental Implants Market offers a thorough understanding on this industry with significant details subject to its overall foothold in the global landscape and its application across major end-user industries and sectors. According to this report, North America dent... Read More

North America Attapulgite Market - A USD 170 million Opportunity by 2024

Published Date: 2020-09-25         Author: Ronak Bora

The study on North America Attapulgite Market provides a complete view on the industry with intricate details subject to its overall stance in the global landscape along with specifying various applications across major end-user sectors. North America attapulgite industry, as per the given report... Read More

North America Biomedical Refrigerators and Freezers Market Size to Exceed USD 1.4 Billion by 2024

Published Date: 2020-09-25         Author: Ronak Bora

The research report on North America Biomedical Refrigerators and Freezers Market provides a comprehensive understanding of the overall market with substantial details including its position in the global economy and its applications across myriad end-users segments. According to the given report... Read More

© 2020 Fractovia. All Rights Reserved